SlideShare a Scribd company logo
Guillaume PLANE
Provantage
®
End-To-End Solutions
ONLY FOR U.S. AND CANADA AUDIENCE
Managing process
scaling and tech
transfer
2 Managing process scaling and tech transfer
Let us start with ICH Q10…
“The goal of technology transfer activities is to transfer product and process
knowledge between development and manufacturing, and within or between
manufacturing sites to achieve product realization. This knowledge forms the
basis for the manufacturing process, control strategy, process validation
approach, and ongoing continual improvement.”
 Transfers have to be performed in an organized, methodical manner, with
appropriate documentation.
 We will focus on the transfer of Drug Substance process parameters and
process knowledge (data).
Technology Transfer
3 Managing process scaling and tech transfer
Process transfers include:
• Transfer from one Process Development group to another, or to Pilot Lab
• Transfer from Process Development to clinical or commercial manufacturing
• Transfer from Process Development to external clinical manufacturing
• Transfer of commercial process between company facilities
• Transfer of commercial process to external contract manufacturing
Greater rigor and documentation are needed for the latter cases, especially transfers between companies.
Best practices discussed here cover the greater level of detail
Scale as appropriate for the situation
Scope of Process Transfers
4 Managing process scaling and tech transfer
Mobius® 2,000 L Single-Use Bioreactor Performances
Production of a mAb with a CHO-S cell line
Define Scale in Advance of Transfer
5 Managing process scaling and tech transfer
Mobius®
2000L Single Use Bioreactor Performances
Production of mAb with CHO-K1 cell line (Cellvento®
CHO 220)
6 Managing process scaling and tech transfer
1. Form tech transfer teams and governance structures, define project charter with goals and timelines
2. Consolidate process knowledge into transferable documentation
3. Gap Analysis / Risk Assessment – leads to detailed project plan
4. Tech Transfer Execution (work the plan)
5. Process “Q/q”ualification – demonstrate technical success
6. Finalize transfer: documentation, support of regulatory activities, follow-up actions, plan for ongoing technical
support, lessons learned
Process Transfer: Key Activities
Transfer does not end at completion of
Qualification lots or approval,
but extends over duration of
manufacturing
7 Managing process scaling and tech transfer
Write Request for Proposal (RFP)
• Provide sufficient detail for accurate assessment
Due Diligence
• Assess capabilities
• Capacity, facility, cGMP, personnel
• High level gap analysis
• Be ready to order long lead time equipment
• Assess feasibility if significant process changes would be required
Write contract
• Be specific on deliverables and expectations
• Ensure terms incentivize rigorous scientific behaviors
Early Planning Stage: often precedes external transfers
8 Managing process scaling and tech transfer
Key content and outcomes from this document must include:
• A well-defined team structure
• Sub-teams for different disciplines
• Connect counterparts
• Establish communication paths
• A well defined governance structure to resolve issues
• Aligned timelines, gating/review points, and goals for deliverables
• Clearly described roles and responsibilities
• Who will be responsible for ongoing support and troubleshooting throughout manufacturing?
• Clearly established success criteria
Set expectations and responsibilities between partners
Project Charter
9 Managing process scaling and tech transfer
A Process Description document with an overview of each step and key process parameters is required
• Information should be described in a site- and scale-independent manner, to focus on intrinsic process
requirements
• Site-specific details from previous process installations should also be gathered as examples
For example:
• Buffers may have been prepared in batch or via in-line dilution
• Bioreactors may have been operated with different sparger configurations
Consolidated Process Knowledge
Use an electronic file sharing system
for document hosting– not email
10 Managing process scaling and tech transfer
Additional Valuable Process Information
Materials
• BOM
• Consumables: bags, filters,
tubing, gaskets, o-rings,
etc.
• Vendors
• Grade
Analytics
• Assays used as part of mfg
process: pH, osmo,
conductivity, OD
• Assays required to support
transfer of scale-down
models
Facility & Equipment
Requirements
• URS/FRS
• Heating/cooling
• Process gas flow rates and
total capacity
• Instrumentation and control
capabilities
• Materials of construction
• Safety assessments,
hazardous material
containment/
disposal
Other Sources of
Process Information
• PD reports
• Validation reports
• Batch records / SOPs
• Historical trends of process
and product data
• License requirements
• Small scale model
instructions and data
• Spreadsheet process models
• Tacit knowledge: cell
morphology, media color,
etc.
11 Managing process scaling and tech transfer
Thorough process walk through:
• Based on Process Description document
• Assesses detailed fit of process in receiving facility
• Identifies areas where changes will be necessary or what differences are acceptable
• Guides project work plan
• Identifies needs for facility modifications
Great process learning exercise for the receiving site!
Gap Analysis
Gaps can be addressed by changing equipment,
procedures, or the process
Changes may require specific new validation studies or may
be covered through the Process Qualification validation
12 Managing process scaling and tech transfer
If you have to make process changes…
• Some process changes are inevitable based on
major differences in facility, equipment, or
operational practices
• Proper experiments must be performed to
determine acceptability of the change. Small-
scale models may be a good tool for
examining the effects of changes
• Pre-defined success criteria are key to timely
progress and decision making- Otherwise, how
do you know if the proposed change is
acceptable?
13 Managing process scaling and tech transfer
Quality Risk Management
What do we do with all these gaps we identified?
Risks are inherent in
technology transfers
Identifying, assessing, and
mitigating
- or -
accepting risks defines the
project work scope of a
transfer
From ICH Q9, two primary principles of quality risk
management are:
• Evaluation of the risk to quality should be based on scientific
knowledge and ultimately link to the protection of the patient
• The level of effort, formality, and documentation of the quality
risk management process should be commensurate with the
level of risk
14 Managing process scaling and tech transfer
Goal: To achieve readiness for process qualification
Mitigate identified risks
• Equipment/facility modifications and validations
Execute process using small scale model – qualify model
Full scale engineering or “water” runs
Author and approve manufacturing instruction documents
• Requires a well-organized system for tracking and managing edits
Training of production and support staff
Tech Transfer Execution
Work the plan…
15 Managing process scaling and tech transfer
Process “Q/q”ualification
Demonstration that the process is performing correctly at the receiving unit
This may be a formal validation exercise or a simple report following an early clinical campaign
Important to have Pre-defined Success Criteria (may or may not be part of Validation protocol)
• Key Process Performance Metrics
• Step yields, impurities, growth rates, titers, etc.
• Product Quality Ranges
• Successful Validation
At key “go/no-go” decision
points, it is helpful for parties
to have agreed in advance
on what success looks like
16 Managing process scaling and tech transfer
Review process performance
• If there are issues to be corrected, assign actions and plan the work
• If failures occurred due to flaws in the methods of transfer, amend
transfer procedures for future executions
Support Regulatory activities
• Document preparation for submissions
• Respond to questions
• Preparation for inspections
Implement systems for ongoing technical support of manufacturing
Complete all documentation
Finalize Transfer
17 Managing process scaling and tech transfer
What if you don’t have to make any changes to your process?
Provantage®
End-to-End Value
Existing Process
New Process
Re-fit Process
New Facility
- We develop your manufacturing process for you
- We fit the process to the updated template while your facility is being built
18 Managing process scaling and tech transfer
Provantage®
End-to-End Value
Proven
Templates
Innovation
Knowledge
Transfer
Tech
Transfer
19 Managing process scaling and tech transfer
Template approach
Save time and money thanks to our ClinicReady™ Template
Clarification
Affinity
Chromatography
Ultrafiltration
Sterile filtration
CEX
Chromatography
Bulk
Drug
Substance
Bioreactor
Virus removal
AEX
Chromatography
20
• At each end of stage, a « Gate Review » is performed to ensure that quality of deliverables is online
with the initial target
• The whole stage is then validated
• Intermediates Go/No Go will also occur during a stage to start activities of the next stage
• Allows a time optimization by perfoming tasks in parallel (fast-tracking)
A stage-gate approach
21
Plant Design
Equipment definition
Module definition
Integration
Final modules
Managing process scaling and tech transfer
22 Managing process scaling and tech transfer
Plant Design
23 Managing process scaling and tech transfer
A brand new facility in a little over a year
L0: GMP
Preclinical
production
L+2:
Process
development
24 Managing process scaling and tech transfer
Upstream Suites
Increased flexibility and lower cost production environment
25 Managing process scaling and tech transfer
26 Managing process scaling and tech transfer
Tech Transfer
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Kick off meeting: Scope, transfer timelines and team members are defined
Team members: At least composed of a project manager, a technical leader and a tech transfer team
Communication plan: Deliverables
Team members with their respective responsibilities
Communication flow path
Meeting frequency
Tech transfer protocol: Equipment
Raw materials and consumables
Detailed process description including critical parameters
Analytical methods
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
Goal: Select parameters from cloning to adapt cells to our internal platform for sub-cloning step
Cloning report:
 Draft version: incomplete (raw mat.) / mistakes (% DMSO) but enough data to launch the project
 Cloning medium composition
 Cloning efficiency
 Direct contact with sending entity (SE) for further information (mail exchange)
 Technical transfer for Downstream Processing & Analytical parts but no Upstream part:
 SE did not perform a sub-cloning phase but only a cloning step
 The sub-cloning phase would not be included in a Tech transfer document (SE expertise)
Case study
In-tech transfer of a cell line
Technical transfer
Productivity
assessment
Selection of 3 best clones
Sub-Cloning I
Failed
Tech. meeting
SE/Merck
Media and Feed
Screening
New medium:
ActiCHO
Sub-cloning II
Failed
Technical meeting
SE/M
June 2015 July 2015 Sept 2015 Nov. 2015 March 2016 May 2016
Current Working Data
 Final version of cloning report: after review from SE based on Merck comments
 Final version of cell line generation report: provided by Customer in order to know all process of pool generation
 From technical meeting SE/Merck (1)
• Composition of Cloning medium modified. (Gln  Gltmx).
 From technical meeting SE/Merck (2)
• Tech. Transfer document unfilled
• “A” clone has suffered during cloning process=> it is a “difficult” clone => The both failures of sub-cloning are
clone dependent. (and not due to a missing data)
• No defined process of sub-cloning from SE: performing of process dev. for each clone.
• Sub-cloning success rate from SE: 90% for sub-cloning of mAb secreting pool, 80% of failure in case of protein
secreting pool.
Case study
In-tech transfer of a cell line
The process has never been running twice within the same template
Robustness of the process has never been demonstrated
Case study
In-tech transfer of a stainless steel process to single use
Kick off
meeting
Team
members
Regulatory and
validation
requirements
Technical and
Quality Agreement
Planning
Communication
plan
Risk analysis
validated
Tech Transfer
Protocol
Reference
material provided
Tech
Transfer
report
Tech
Transfer
Closure
Experiments
Process is not robust, even Quality
Attributes of the product
Decision to redevelop a process
Tech transfer is not only related to the transfer of a process,
but to the transfer of a process and its associated issues
31 Managing process scaling and tech transfer
Questions?
Proven
Templates
Innovation
Knowledge
Transfer
Tech
Transfer
Managing Process Scale-up and Tech Transfer 

More Related Content

PPTX
Technology transfer
PPTX
Technology transfer
PPTX
Modernizing Quality Management
PPTX
Operational Excellence in Pharma Industry
PDF
Project Management In Pharmaceutical Industry
PPTX
IT NPI Process
PPTX
Project management in pharmaceutical generic industry basics and standards
PPTX
Supplier qualification
Technology transfer
Technology transfer
Modernizing Quality Management
Operational Excellence in Pharma Industry
Project Management In Pharmaceutical Industry
IT NPI Process
Project management in pharmaceutical generic industry basics and standards
Supplier qualification

What's hot (20)

PDF
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
PDF
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
PDF
Managing Process Scale-up and Tech Transfer 
PPTX
The Role of Process Characterization in Process Validation
PPTX
Quality standards as per iso
PDF
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
PPTX
CASE STUDY ON CHANGE CONTROL
PDF
A Framework for Technology Transfer
PDF
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
PPTX
Quality metrics
PPTX
Who Guidance on Process Validation for Non Serile Pharmaceuticals
PPTX
Good Automated Manufacturing Practices(GAMP).pptx
PPTX
ICH Q 10 guidline
PDF
CAPA: A Risk Mitigating Quality System
PPTX
Pharmaceutical process validation.pptx
PPTX
Facility Qualification & Consideration of Validation Aspects
PPTX
Deviation and root cause analysis in Pharma
PPT
PPTX
ISO 9001 2008 Part I
PPTX
Application of Q R M in Manufacturing Operations
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Tech transfer and Scale-up - Tips and tricks from a Biodevelopment center
Managing Process Scale-up and Tech Transfer 
The Role of Process Characterization in Process Validation
Quality standards as per iso
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
CASE STUDY ON CHANGE CONTROL
A Framework for Technology Transfer
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Quality metrics
Who Guidance on Process Validation for Non Serile Pharmaceuticals
Good Automated Manufacturing Practices(GAMP).pptx
ICH Q 10 guidline
CAPA: A Risk Mitigating Quality System
Pharmaceutical process validation.pptx
Facility Qualification & Consideration of Validation Aspects
Deviation and root cause analysis in Pharma
ISO 9001 2008 Part I
Application of Q R M in Manufacturing Operations
Ad

Similar to Managing Process Scale-up and Tech Transfer  (20)

PPTX
Technology transfer in Pharmaceutical Industry.pptx
PPTX
Technology transfer.pptx
PDF
Winning Strategies for Tech Transfer Projects
PDF
Winning Strategies for Tech Transfer Projects
DOCX
Technology transfer
PPTX
Technology development and transfer.pptx
PPTX
Technology transfer plan & exhibit
PPT
Technology Transfer
PPTX
Product development and technology transfer M pharm
PPTX
UNIT II Technology development and transfer.pptx
PDF
Insourcing and Production ScaleUp Strategy
PDF
Design Quality Scale Up Automation Strategy
PPT
Training technology transfer training
PPTX
Technology transfer from R & D to production in pharmaceutical industry
PDF
Unit-II TDT-PDF.pdf, expecially in technology transfer.
PDF
Technology transfer 14 p5 millili
PPTX
B1-Technology development and transfer - ppt - part 1.pptx
PPTX
CURRENT ASPECTS OF TECHNOLOGY TRANSFER IN PHARMACEUTICAL INDUSTRY
PDF
Models of Technology Transfer.pdf
PPTX
Technology transfer MANASI .pptx
Technology transfer in Pharmaceutical Industry.pptx
Technology transfer.pptx
Winning Strategies for Tech Transfer Projects
Winning Strategies for Tech Transfer Projects
Technology transfer
Technology development and transfer.pptx
Technology transfer plan & exhibit
Technology Transfer
Product development and technology transfer M pharm
UNIT II Technology development and transfer.pptx
Insourcing and Production ScaleUp Strategy
Design Quality Scale Up Automation Strategy
Training technology transfer training
Technology transfer from R & D to production in pharmaceutical industry
Unit-II TDT-PDF.pdf, expecially in technology transfer.
Technology transfer 14 p5 millili
B1-Technology development and transfer - ppt - part 1.pptx
CURRENT ASPECTS OF TECHNOLOGY TRANSFER IN PHARMACEUTICAL INDUSTRY
Models of Technology Transfer.pdf
Technology transfer MANASI .pptx
Ad

More from MilliporeSigma (20)

PDF
Launch of our new Titanium Dioxide Alternative
PDF
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
PDF
Use of Excipients in Downstream Processing to Improve Protein Purification
PDF
Exploring the protein stabilizing capability of surfactants against agitation...
PDF
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
PDF
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
PDF
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
PDF
The Future of Pharma- and Biopharmaceutical Audits
PDF
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
PDF
Identity testing by NGS as a means of risk mitigation for viral gene therapies
PDF
Latest advancements of melt based 3D printing technologies for oral drug deli...
PDF
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
PDF
How does the ICH Q5A revision impact viral safety strategies for biologics?
PDF
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
PDF
Insights from a Global Collaboration Accelerating Vaccine Development with an...
PDF
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
PDF
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
PDF
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
PDF
The Developability Classification System (DCS): Enabling an Optimized Approac...
PDF
How to Accelerate and Enhance ADC Therapies
Launch of our new Titanium Dioxide Alternative
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
Use of Excipients in Downstream Processing to Improve Protein Purification
Exploring the protein stabilizing capability of surfactants against agitation...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Future of Pharma- and Biopharmaceutical Audits
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Latest advancements of melt based 3D printing technologies for oral drug deli...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
How does the ICH Q5A revision impact viral safety strategies for biologics?
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The Developability Classification System (DCS): Enabling an Optimized Approac...
How to Accelerate and Enhance ADC Therapies

Recently uploaded (20)

PPT
KULIAH UG WANITA Prof Endang 121110 (1).ppt
PPTX
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
PDF
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
PDF
2E-Learning-Together...PICS-PCISF con.pdf
PDF
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
PPT
Microscope is an instrument that makes an enlarged image of a small object, t...
PPTX
Bronchial_Asthma_in_acute_exacerbation_.pptx
PPTX
Infection prevention and control for medical students
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PPT
Recent advances in Diagnosis of Autoimmune Disorders
PPTX
Basics of pharmacology (Pharmacology I).pptx
PPTX
CBT FOR OCD TREATMENT WITHOUT MEDICATION
PPTX
different types of Gait in orthopaedic injuries
PPTX
Trichuris trichiura infection
PPT
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
PDF
DAY-6. Summer class. Ppt. Cultural Nursing
PPTX
HEMODYNAMICS - I DERANGEMENTS OF BODY FLUIDS.pptx
PPTX
Galactosemia pathophysiology, clinical features, investigation and treatment ...
PPTX
Genaralised anxiety disorder presentation
KULIAH UG WANITA Prof Endang 121110 (1).ppt
NUTRITIONAL PROBLEMS, CHANGES NEEDED TO PREVENT MALNUTRITION
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
2E-Learning-Together...PICS-PCISF con.pdf
Khaled Sary- Trailblazers of Transformation Middle East's 5 Most Inspiring Le...
Microscope is an instrument that makes an enlarged image of a small object, t...
Bronchial_Asthma_in_acute_exacerbation_.pptx
Infection prevention and control for medical students
Medical aspects of impairment including all the domains mentioned in ICF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Recent advances in Diagnosis of Autoimmune Disorders
Basics of pharmacology (Pharmacology I).pptx
CBT FOR OCD TREATMENT WITHOUT MEDICATION
different types of Gait in orthopaedic injuries
Trichuris trichiura infection
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
DAY-6. Summer class. Ppt. Cultural Nursing
HEMODYNAMICS - I DERANGEMENTS OF BODY FLUIDS.pptx
Galactosemia pathophysiology, clinical features, investigation and treatment ...
Genaralised anxiety disorder presentation

Managing Process Scale-up and Tech Transfer 

  • 1. Guillaume PLANE Provantage ® End-To-End Solutions ONLY FOR U.S. AND CANADA AUDIENCE Managing process scaling and tech transfer
  • 2. 2 Managing process scaling and tech transfer Let us start with ICH Q10… “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement.”  Transfers have to be performed in an organized, methodical manner, with appropriate documentation.  We will focus on the transfer of Drug Substance process parameters and process knowledge (data). Technology Transfer
  • 3. 3 Managing process scaling and tech transfer Process transfers include: • Transfer from one Process Development group to another, or to Pilot Lab • Transfer from Process Development to clinical or commercial manufacturing • Transfer from Process Development to external clinical manufacturing • Transfer of commercial process between company facilities • Transfer of commercial process to external contract manufacturing Greater rigor and documentation are needed for the latter cases, especially transfers between companies. Best practices discussed here cover the greater level of detail Scale as appropriate for the situation Scope of Process Transfers
  • 4. 4 Managing process scaling and tech transfer Mobius® 2,000 L Single-Use Bioreactor Performances Production of a mAb with a CHO-S cell line Define Scale in Advance of Transfer
  • 5. 5 Managing process scaling and tech transfer Mobius® 2000L Single Use Bioreactor Performances Production of mAb with CHO-K1 cell line (Cellvento® CHO 220)
  • 6. 6 Managing process scaling and tech transfer 1. Form tech transfer teams and governance structures, define project charter with goals and timelines 2. Consolidate process knowledge into transferable documentation 3. Gap Analysis / Risk Assessment – leads to detailed project plan 4. Tech Transfer Execution (work the plan) 5. Process “Q/q”ualification – demonstrate technical success 6. Finalize transfer: documentation, support of regulatory activities, follow-up actions, plan for ongoing technical support, lessons learned Process Transfer: Key Activities Transfer does not end at completion of Qualification lots or approval, but extends over duration of manufacturing
  • 7. 7 Managing process scaling and tech transfer Write Request for Proposal (RFP) • Provide sufficient detail for accurate assessment Due Diligence • Assess capabilities • Capacity, facility, cGMP, personnel • High level gap analysis • Be ready to order long lead time equipment • Assess feasibility if significant process changes would be required Write contract • Be specific on deliverables and expectations • Ensure terms incentivize rigorous scientific behaviors Early Planning Stage: often precedes external transfers
  • 8. 8 Managing process scaling and tech transfer Key content and outcomes from this document must include: • A well-defined team structure • Sub-teams for different disciplines • Connect counterparts • Establish communication paths • A well defined governance structure to resolve issues • Aligned timelines, gating/review points, and goals for deliverables • Clearly described roles and responsibilities • Who will be responsible for ongoing support and troubleshooting throughout manufacturing? • Clearly established success criteria Set expectations and responsibilities between partners Project Charter
  • 9. 9 Managing process scaling and tech transfer A Process Description document with an overview of each step and key process parameters is required • Information should be described in a site- and scale-independent manner, to focus on intrinsic process requirements • Site-specific details from previous process installations should also be gathered as examples For example: • Buffers may have been prepared in batch or via in-line dilution • Bioreactors may have been operated with different sparger configurations Consolidated Process Knowledge Use an electronic file sharing system for document hosting– not email
  • 10. 10 Managing process scaling and tech transfer Additional Valuable Process Information Materials • BOM • Consumables: bags, filters, tubing, gaskets, o-rings, etc. • Vendors • Grade Analytics • Assays used as part of mfg process: pH, osmo, conductivity, OD • Assays required to support transfer of scale-down models Facility & Equipment Requirements • URS/FRS • Heating/cooling • Process gas flow rates and total capacity • Instrumentation and control capabilities • Materials of construction • Safety assessments, hazardous material containment/ disposal Other Sources of Process Information • PD reports • Validation reports • Batch records / SOPs • Historical trends of process and product data • License requirements • Small scale model instructions and data • Spreadsheet process models • Tacit knowledge: cell morphology, media color, etc.
  • 11. 11 Managing process scaling and tech transfer Thorough process walk through: • Based on Process Description document • Assesses detailed fit of process in receiving facility • Identifies areas where changes will be necessary or what differences are acceptable • Guides project work plan • Identifies needs for facility modifications Great process learning exercise for the receiving site! Gap Analysis Gaps can be addressed by changing equipment, procedures, or the process Changes may require specific new validation studies or may be covered through the Process Qualification validation
  • 12. 12 Managing process scaling and tech transfer If you have to make process changes… • Some process changes are inevitable based on major differences in facility, equipment, or operational practices • Proper experiments must be performed to determine acceptability of the change. Small- scale models may be a good tool for examining the effects of changes • Pre-defined success criteria are key to timely progress and decision making- Otherwise, how do you know if the proposed change is acceptable?
  • 13. 13 Managing process scaling and tech transfer Quality Risk Management What do we do with all these gaps we identified? Risks are inherent in technology transfers Identifying, assessing, and mitigating - or - accepting risks defines the project work scope of a transfer From ICH Q9, two primary principles of quality risk management are: • Evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient • The level of effort, formality, and documentation of the quality risk management process should be commensurate with the level of risk
  • 14. 14 Managing process scaling and tech transfer Goal: To achieve readiness for process qualification Mitigate identified risks • Equipment/facility modifications and validations Execute process using small scale model – qualify model Full scale engineering or “water” runs Author and approve manufacturing instruction documents • Requires a well-organized system for tracking and managing edits Training of production and support staff Tech Transfer Execution Work the plan…
  • 15. 15 Managing process scaling and tech transfer Process “Q/q”ualification Demonstration that the process is performing correctly at the receiving unit This may be a formal validation exercise or a simple report following an early clinical campaign Important to have Pre-defined Success Criteria (may or may not be part of Validation protocol) • Key Process Performance Metrics • Step yields, impurities, growth rates, titers, etc. • Product Quality Ranges • Successful Validation At key “go/no-go” decision points, it is helpful for parties to have agreed in advance on what success looks like
  • 16. 16 Managing process scaling and tech transfer Review process performance • If there are issues to be corrected, assign actions and plan the work • If failures occurred due to flaws in the methods of transfer, amend transfer procedures for future executions Support Regulatory activities • Document preparation for submissions • Respond to questions • Preparation for inspections Implement systems for ongoing technical support of manufacturing Complete all documentation Finalize Transfer
  • 17. 17 Managing process scaling and tech transfer What if you don’t have to make any changes to your process? Provantage® End-to-End Value Existing Process New Process Re-fit Process New Facility - We develop your manufacturing process for you - We fit the process to the updated template while your facility is being built
  • 18. 18 Managing process scaling and tech transfer Provantage® End-to-End Value Proven Templates Innovation Knowledge Transfer Tech Transfer
  • 19. 19 Managing process scaling and tech transfer Template approach Save time and money thanks to our ClinicReady™ Template Clarification Affinity Chromatography Ultrafiltration Sterile filtration CEX Chromatography Bulk Drug Substance Bioreactor Virus removal AEX Chromatography
  • 20. 20 • At each end of stage, a « Gate Review » is performed to ensure that quality of deliverables is online with the initial target • The whole stage is then validated • Intermediates Go/No Go will also occur during a stage to start activities of the next stage • Allows a time optimization by perfoming tasks in parallel (fast-tracking) A stage-gate approach
  • 21. 21 Plant Design Equipment definition Module definition Integration Final modules Managing process scaling and tech transfer
  • 22. 22 Managing process scaling and tech transfer Plant Design
  • 23. 23 Managing process scaling and tech transfer A brand new facility in a little over a year L0: GMP Preclinical production L+2: Process development
  • 24. 24 Managing process scaling and tech transfer Upstream Suites Increased flexibility and lower cost production environment
  • 25. 25 Managing process scaling and tech transfer
  • 26. 26 Managing process scaling and tech transfer
  • 27. Tech Transfer Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Kick off meeting: Scope, transfer timelines and team members are defined Team members: At least composed of a project manager, a technical leader and a tech transfer team Communication plan: Deliverables Team members with their respective responsibilities Communication flow path Meeting frequency Tech transfer protocol: Equipment Raw materials and consumables Detailed process description including critical parameters Analytical methods Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments
  • 28. Goal: Select parameters from cloning to adapt cells to our internal platform for sub-cloning step Cloning report:  Draft version: incomplete (raw mat.) / mistakes (% DMSO) but enough data to launch the project  Cloning medium composition  Cloning efficiency  Direct contact with sending entity (SE) for further information (mail exchange)  Technical transfer for Downstream Processing & Analytical parts but no Upstream part:  SE did not perform a sub-cloning phase but only a cloning step  The sub-cloning phase would not be included in a Tech transfer document (SE expertise) Case study In-tech transfer of a cell line Technical transfer Productivity assessment Selection of 3 best clones Sub-Cloning I Failed Tech. meeting SE/Merck Media and Feed Screening New medium: ActiCHO Sub-cloning II Failed Technical meeting SE/M June 2015 July 2015 Sept 2015 Nov. 2015 March 2016 May 2016
  • 29. Current Working Data  Final version of cloning report: after review from SE based on Merck comments  Final version of cell line generation report: provided by Customer in order to know all process of pool generation  From technical meeting SE/Merck (1) • Composition of Cloning medium modified. (Gln  Gltmx).  From technical meeting SE/Merck (2) • Tech. Transfer document unfilled • “A” clone has suffered during cloning process=> it is a “difficult” clone => The both failures of sub-cloning are clone dependent. (and not due to a missing data) • No defined process of sub-cloning from SE: performing of process dev. for each clone. • Sub-cloning success rate from SE: 90% for sub-cloning of mAb secreting pool, 80% of failure in case of protein secreting pool. Case study In-tech transfer of a cell line
  • 30. The process has never been running twice within the same template Robustness of the process has never been demonstrated Case study In-tech transfer of a stainless steel process to single use Kick off meeting Team members Regulatory and validation requirements Technical and Quality Agreement Planning Communication plan Risk analysis validated Tech Transfer Protocol Reference material provided Tech Transfer report Tech Transfer Closure Experiments Process is not robust, even Quality Attributes of the product Decision to redevelop a process Tech transfer is not only related to the transfer of a process, but to the transfer of a process and its associated issues
  • 31. 31 Managing process scaling and tech transfer Questions? Proven Templates Innovation Knowledge Transfer Tech Transfer